# | ||||
---|---|---|---|---|
1 | IO-EMP Tissue-derived acellular micro-scaffold technology reducing or eliminating diabetics’ dependence oninsulin therapy | 2017 | 71˙429.00 | 50˙000.00 |
2 | CELLS IN MATRIX Cells in Matrix – an innovative 3D model for R&D of Diabetes | 2020 | 3˙340˙842.00 | 2˙640˙417.00 |